Symbols

ASBP

Aspire Biopharma·NASDAQ

--(--)

7.16 / 10

Outperform

Analyst coverage is absent (ana_eval -1). Fund flow scores 7.16/10 (good), with overall inflow ratio 0.47 but a negative trend. Small‑cap investors show positive inflow, while block, medium, large, and extra‑large remain negative, suggesting mixed sentiment.

Fund Flow Rating

What is the market sentiment for ASBP?

ASBP holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.16/10 (Outperform).